deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT01541254

Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device (LVIS)

A Feasibility Study of the MicroVention,Inc.(LVIS™) Neurovascular Self-Expanding Retrievable Stent System in the Treatment of Wide-Necked Intracranial Artery Aneurysms

Sponsor: Microvention-Terumo, Inc.

Updated 7 times since 2017 Last updated: Jun 13, 2025 Started: Mar 31, 2012 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Intracranial Aneurysms, this trial is completed. The trial is conducted by Microvention-Terumo, Inc. and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshotCompleted~Aug 2025 – present · 12 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Aug 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Aug 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

Show 2 earlier versions
  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Microvention-Terumo, Inc.
Data source: Microvention-Terumo, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .